To examine how CCL20 contributes to bone metastasis of breast cancer cells, we evaluated the effects of CCL20 treatment on the proliferation (Fig. 5a,b), migration (Fig. 5c), and invasion (Fig. 5d) of MDA-MB-231 cells. Here, CCL20 is linked to breast carcinoma.